N ucleotides are compounds of critical importance to cellular function, and although not essential dietary nutrients, it has been demonstrated that supplementation of pediatric formulas with nucleotides is of benefit in neonatal nutrition. The described method was developed to provide an accurate, rapid, and robust technique for the routine compliance testing of uridine 5′-monophosphate (UMP), inosine 5′-monophosphate (IMP), adenosine 5′-monophosphate (AMP), guanosine 5′-monophosphate (GMP), and cytidine 5′-monophosphate (CMP) in infant formula and adult/pediatric nutritional formula, and was recently reported (1) .
In September 2011, the method was reviewed by an AOAC expert review panel and, based on the published single- (Applicable to the determination of 5′-mononucleotides in infant formula and adult/pediatric nutritional formula.) Caution: Refer to the material safety data sheets for all chemicals prior to use. Use all appropriate personal protective equipment, and follow good laboratory practices.
A. Principle
Sample is dissolved in high-salt solution to inhibit protein and fat interactions. The 5′-mononucleotides-uridine 5′-monophosphate (UMP), inosine 5′-monophosphate (IMP), adenosine 5′-monophosphate (AMP), guanosine 5′-monophosphate (GMP), and cytidine 5′-phosphate (CMP)-are separated from the sample matrix by strong-anion exchange solid-phase extraction (SPE), followed by chromatographic analysis using a C 18 stationary phase with gradient elution, UV detection, and quantitation by an internal standard technique using thymidine 5′-monophosphate (TMP).
B. Apparatus
(a) HPLC system.-Equipped with pump, sample injector unit with a 50 μL injection loop, degasser unit, column oven, and photodiode array detector.
( 
E. Standard Preparation
See Table 2011 .20A for the UV absorbance maxima and extinction coefficients for 5′-mononucleotides. 
G. Extraction
Throughout the extraction procedure, do not let the cartridge run dry but drain to the top of the cartridge bed only. When draining the cartridge the flow rate should be <2 mL/min. (f) Filter an aliquot (~2 mL) of the eluent through a 0.2 µm syringe filter into an autosampler vial.
H. Chromatography
(a) Form gradients by low pressure mixing of the two mobile phases, A and B, with separation of nucleotides achieved using the procedure shown in Table 2011 .20C.
(b) Acquire spectral data between 210 and 300 nm by the photodiode array detector with chromatograms monitored at the specified wavelengths below for quantitation.
(1) IMP wavelength at 250 nm. where wtSS = weight of nucleotide in stock standard (g); 50 = total volume of stock standard (mL); 10 6 = concentration conversion (g/mL to µg/mL); P% = purity (%); 100 = mass conversion from % to decimal. (c) Concentration of TMP in internal standard:
Internal standard, µg/mL = 50
where SS = concentration of nucleotide in stock standard (µg/mL); 4 = volume of stock standard in internal standard (mL); 50 = total volume of internal standard (mL).
(d) Concentration of nucleotide in calibration standards:
Calibration standard, µg/mL = 25 50
where SS = concentration of nucleotide in stock standard (µg/mL); 2 = volume of stock standard in working standard (mL); 50 = total volume of working standard (mL); VS = volume of working standard in calibration standard (mL); 25 = total volume of calibration standard (mL).
(e) Concentration of TMP in calibration standards:
where IS = concentration of TMP in internal standard (µg/mL); 1 = volume of working standard in calibration standard (mL); 25 = total volume of calibration standard (mL).
(f) Determine the linear regression curve for the ratio of peaks areas (nucleotide/TMP; y-axis) vs the ratio of concentrations (nucleotide/TMP; x-axis) for calibration standards and calculate the slope with the y-intercept forced through 0.
(g) Interpolate the nucleotide contents in unknown samples from this calibration curve.
For powders:
Nucleotide, mg/hg = 1000 C IS = concentration of internal standard added to sample (µg/mL); V IS = volume of internal standard added to sample (mL); W S = weight of sample (g); 100 = mass conversion of result (g to hg); 1000 = mass conversion of result (µg to mg); V S = volume of sample (mL); 100 = volume conversion of result (mL to dL).
J. Data Handling
Report results in mg/hg to 1 decimal place. Reference: J. AOAC Int. 95, XXX(2012)
Results and Discussion
An SLV of the method previously published (1) indicated that this method is suitable for the routine determination of the 5′-mononucleotide content in milk and milk-based pediatric and adult nutritional products. The validation parameters investigated included linearity and working range, method detection limit, accuracy as recovery and bias, precision as repeatability and intermediate precision, and robustness. Linearity was demonstrated for all five nucleotides with correlation coefficients of >0.9999, and a visual inspection of residual plots. The method detection limits for individual nucleotides ranged from 0.06 to 0.19 mg/kg. The working range for individual nucleotides evaluated was from 0.06 to 17.4 mg/kg. Accuracy was determined as recovery, with values measured from 92 to 101%, within the suggested AOAC limits of 80−115% at the 10 ppm level (3), and no bias was found (P values all >0.05) when compared with a The method was applied to the analysis of a number of commercially available pediatric and nutritional powders. The products used for sampling included infant formula, follow-on formulas, and an adult nutritional product. The range of sources for these products included bovine milk, hydrolyzed milk protein, caprine milk, and soy protein. The method was found to be suitable for use with these various product matrixes.
It is recommended that this method be further examined against a set of infant formula and adult nutritional matrixes developed for this purpose by the SPIFAN community, and its performance evaluated against the SMPRs established by SPIFAN.
